BENNETT C FRANK 4
4 · IONIS PHARMACEUTICALS INC · Filed Jan 6, 2026
Insider Transaction Report
Form 4
BENNETT C FRANK
EVP, Chief Scientific Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2026-01-02+19,350→ 19,350 totalExercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (19,350 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.